Effects of Sub-Occipital Myofascial Release in Patients With Cervicogenic Headache
1 other identifier
interventional
22
1 country
1
Brief Summary
Cervicogenic headache is a secondary form of headache that occurs from the upper cervical spine and atlanto-occipital joint. A CGH is a frequent source of chronic headache and is frequently misdiagnosed .Cervicogenic headache is among the most common problem affecting four times more women as compared to males and is considered by some painful feeling in the head , neck ,temporal area, frontal area and around the eyes areas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedFirst Submitted
Initial submission to the registry
March 24, 2021
CompletedFirst Posted
Study publicly available on registry
March 25, 2021
CompletedAugust 30, 2021
August 1, 2021
8 months
March 24, 2021
August 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain Numeric Rating Scale
Pain Numeric Rating Scale (PNRS) scores in subjects with moderate/severe pain at baseline. \*P \< 0.0001 vs. baseline. Includes only subjects with baseline PNRS score of 4 to 10. Scale ranges from 0 to 10.
4 months
NECK DISABILITY INDEX
the overall score range is between 0 and 50, 0 being no to little pain and discomfort while 50 being the severest degree of pain and disability with complete activity limitation.
4 months
Study Arms (2)
Studygroup
EXPERIMENTALcervical mobilization (Headache SNAG) with baseline treatment (Hot pack for 10 minutes, TENS 10 minutes, Neck isometrics and stretching).
Control Group
ACTIVE COMPARATORSub-occipital myofascial release with baseline treatment (Hot pack for 10 minutes, TENS for 10 minutes, Neck isometrics and stretching
Interventions
For cervical mobilization the patient's position is sitting on a chair in the erect posture. The therapist handled C2 spinous process with the middle phalanx of one hand. With the other hand, he performed ventral glide asked the patient to move neck in all directions (Flexion, Extension, Side bending and rotation) one by one and then slowly move the neck back to its starting position while the therapist maintained the ventral glide.
For the application of the technique , the patient position is supine lying with the head fully supported on therapist's hands and therapist places 3 middle fingers just inferior to the nuchal line, lifts the fingers tips towards the ceiling while resting the head on the table and then therapist will apply a gentle upward pull. This procedure done for 2 to 3 minutes and 5 to 7 repetitions, 3 sessions per week on alternate days were given for 6 weeks. Evaluation was done before treatment, during treatment at 4th week and after treatment at 6th week. Outcomes will be measured by NDI, PNRS and Universal Goniometer.
Eligibility Criteria
You may qualify if:
- Both Genders
- Age between 20 to 75 Years
- Neck pain referring the unilateral pain to the sub-occipital region and head.
- Headache intensifying upon manual pressure to upper cervical joints and muscles
- With the cranio-cervical Flexion rotation exam, neck pain and ipsilateral headache and restriction of C1 and C2 rotation.
You may not qualify if:
- Tension headache (Headache on both sides)
- If the patient not tolerate the cranio-cervical Flexion rotation test.
- Patients presents with autonomic symptoms like visual disturbance, vertigo, dizziness.
- If the physiotherapeutic modalities used for head pain in the last 6 months.
- Headache other than cervical origins.
- Clinically diagnosed as case of cervical radiculopathy or myelopathy.
- Extreme cervical discomfort due to disk herniation, stenosis of the spinal canal and cervical arthritis.
- Each other disorder that may be contraindicated in the upper cervical area of myofascial release.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riphah Rehabilitation Center
Lahore, Punjab Province, 54000, Pakistan
Related Publications (7)
Singh LR, Chauhan V. Comparison of efficacy of myofascial release and positional release therapy in tension type headache. JMSCR. 2014;2(9):2372-9.
BACKGROUNDRacicki S, Gerwin S, Diclaudio S, Reinmann S, Donaldson M. Conservative physical therapy management for the treatment of cervicogenic headache: a systematic review. J Man Manip Ther. 2013 May;21(2):113-24. doi: 10.1179/2042618612Y.0000000025.
PMID: 24421621BACKGROUNDBiondi DM. Cervicogenic headache: a review of diagnostic and treatment strategies. J Am Osteopath Assoc. 2005 Apr;105(4 Suppl 2):16S-22S.
PMID: 15928349BACKGROUNDAntonaci F, Sjaastad O. Cervicogenic headache: a real headache. Curr Neurol Neurosci Rep. 2011 Apr;11(2):149-55. doi: 10.1007/s11910-010-0164-9.
PMID: 21125430BACKGROUNDFredriksen TA, Salvesen R, Stolt-Nielsen A, Sjaastad O. Cervicogenic headache: long-term postoperative follow-up. Cephalalgia. 1999 Dec;19(10):897-900. doi: 10.1046/j.1468-2982.1999.1910897.x.
PMID: 10668109BACKGROUNDBogduk N. Cervicogenic headache: anatomic basis and pathophysiologic mechanisms. Curr Pain Headache Rep. 2001 Aug;5(4):382-6. doi: 10.1007/s11916-001-0029-7.
PMID: 11403743BACKGROUNDBovim G, Berg R, Dale LG. Cervicogenic headache: anesthetic blockades of cervical nerves (C2-C5) and facet joint (C2/C3). Pain. 1992 Jun;49(3):315-320. doi: 10.1016/0304-3959(92)90237-6.
PMID: 1408296BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maryam Shabbir, MS
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2021
First Posted
March 25, 2021
Study Start
April 1, 2020
Primary Completion
November 30, 2020
Study Completion
December 30, 2020
Last Updated
August 30, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share